GB1262830A - Novel sydnonimine derivative - Google Patents

Novel sydnonimine derivative

Info

Publication number
GB1262830A
GB1262830A GB2810170A GB2810170A GB1262830A GB 1262830 A GB1262830 A GB 1262830A GB 2810170 A GB2810170 A GB 2810170A GB 2810170 A GB2810170 A GB 2810170A GB 1262830 A GB1262830 A GB 1262830A
Authority
GB
United Kingdom
Prior art keywords
methylphenethyl
imine
novel
phenylcarbamoyl
novel compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2810170A
Inventor
Mikhail Davidovich Mashkovsky
Vladimir Genrikhovic Yashunsky
Roald Abramovich Altshuller
Leonid Erimovich Knolodov
Grigory Yakovlevich Avrutsky
Jury Anatolievic Alexandrovsky
Anatoly Boleslavovic Smulevich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vni Khim Farmatsevtichesky I I
Original Assignee
Vni Khim Farmatsevtichesky I I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vni Khim Farmatsevtichesky I I filed Critical Vni Khim Farmatsevtichesky I I
Priority to GB2810170A priority Critical patent/GB1262830A/en
Publication of GB1262830A publication Critical patent/GB1262830A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/041,2,3-Oxadiazoles; Hydrogenated 1,2,3-oxadiazoles

Abstract

1,262,830. 3-(α-Methylphenethyl)-N-(phenylcarbamoyl)-sydnone imine. VSESOJUZNY NAUCHNO-ISSLEDOVATELSKY KHIMIKO-FARMATSEVTICHESKY INSTITUT IMENI S. ORDZHONIKIDZE. 10 June, 1970, No. 28101/70. Heading C2L. The novel compound, 3-(α-methylphenethyl)- N-(phenylcarbamoyl)-sydnone imine, is obtained by reacting 3-(α-methylphenethyl)-syndone imine hydrochloride with phenyl isocyanate in a polar solvent in the presence of sodium acetate. Pharmaceutical compositions, having a stimulating effect on the central nervous system and suitable for oral administration, contain the above novel compound and pharmaceutically acceptable diluents.
GB2810170A 1970-06-10 1970-06-10 Novel sydnonimine derivative Expired GB1262830A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB2810170A GB1262830A (en) 1970-06-10 1970-06-10 Novel sydnonimine derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2810170A GB1262830A (en) 1970-06-10 1970-06-10 Novel sydnonimine derivative

Publications (1)

Publication Number Publication Date
GB1262830A true GB1262830A (en) 1972-02-09

Family

ID=10270292

Family Applications (1)

Application Number Title Priority Date Filing Date
GB2810170A Expired GB1262830A (en) 1970-06-10 1970-06-10 Novel sydnonimine derivative

Country Status (1)

Country Link
GB (1) GB1262830A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050916A2 (en) * 1980-10-02 1982-05-05 American Home Products Corporation CNS stimulants and antihypertensive agents
US8415385B2 (en) 2007-03-14 2013-04-09 Hao Chen Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders
US8691853B2 (en) 2007-03-14 2014-04-08 Caliper Life Sciences, Inc. Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
WO2014145126A2 (en) 2013-03-15 2014-09-18 Melior Discovery, Inc. Methods of treating dyskinesia and related disorders
US9119843B2 (en) 2009-12-04 2015-09-01 Caliper Life Sciences, Inc. Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0050916A2 (en) * 1980-10-02 1982-05-05 American Home Products Corporation CNS stimulants and antihypertensive agents
EP0050916A3 (en) * 1980-10-02 1982-06-02 American Home Products Corporation Cns stimulants and antihypertensive agents
US8415385B2 (en) 2007-03-14 2013-04-09 Hao Chen Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders
US8691853B2 (en) 2007-03-14 2014-04-08 Caliper Life Sciences, Inc. Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
US9149466B2 (en) 2007-03-14 2015-10-06 Caliper Life Sciences, Inc. Method of using dopamine reuptake inhibitors and their analogs for treating autoimmune conditions and delaying or preventing autoimmune related pathologic progressions
US9604945B2 (en) 2007-03-14 2017-03-28 Caliper Life Sciences, Inc. Sydnonimines-specific dopamine reuptake inhibitors and their use in treating dopamine related disorders
US9119843B2 (en) 2009-12-04 2015-09-01 Caliper Life Sciences, Inc. Method of using dopamine reuptake inhibitors and their analogs for treating diabetes symptoms and delaying or preventing diabetes-associated pathologic conditions
WO2014145126A2 (en) 2013-03-15 2014-09-18 Melior Discovery, Inc. Methods of treating dyskinesia and related disorders

Similar Documents

Publication Publication Date Title
GB1222708A (en) Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
GB1388358A (en) Taste-improving formulations of oral penicillins
GB1262830A (en) Novel sydnonimine derivative
GB1154742A (en) Pyrrylamino Ketones
GB1293507A (en) Derivatives of 3-carbamoyl-2-oxazolidinone, and their process of preparation
GB1289240A (en)
ES432027A1 (en) Pharmacologically active anilinobenzothiazoles
GB1322112A (en) 3,4,5-trimethoxybenzoic acid derivatives and their uses
GB1280290A (en) Novel derivatives of benzhydrylpiperazine, their process of preparation and their therapeutic application
GB1341955A (en) Aryl 4-piperidyl ketone derivatives
GB1394791A (en) Diphenylalkyllactamimide derivatives
ES343995A1 (en) 2-beta-hydroxy ethylamino-4-5-diphenyl-oxazole
GB1141214A (en) New derivatives of proscillaridin a
GB1163870A (en) Anti-Seborrhocic Compositions Suitable for Oral Administration
GB1421589A (en) Salicylanilide derivatives
GB1315355A (en) Benzotriazole derivatives
ES376793A2 (en) Novel n-substituted amines and their process of preparation
GB1468557A (en) Pharmaceutical composition containing hexetidine
FR2332757A1 (en) (3)-Carbamoyl-substd. heterocyclyl thio-methyl cephalosporins - antibacterials useful in human or veterinary medicine
GB1384523A (en) Oxime derivatives and their preparation
GB1317125A (en) Piperazine compositions and method of treatment
GB1420976A (en) Pharmaceutical compositions for use in the treatment of certain respiratory diseases or conditions in prematurely born children
GB1368251A (en) Theophylinylmethylethanoic acid ester
GB1299037A (en) Dithiocarbamic acid esters
GB1290827A (en)